Scope and Claims Analysis of U.S. Patent 7,851,504
What Are the Patent’s Core Claims and How Broad Is Its Coverage?
U.S. Patent 7,851,504 covers a novel class of chemical compounds designed for therapeutic applications, particularly targeting specific disease mechanisms. The patent's claims primarily focus on:
- The chemical structure of these compounds, defined by a core scaffold with specific substituents.
- Methods of synthesizing the compounds.
- Pharmaceutical compositions containing the compounds.
- Use of the compounds in treating certain diseases.
Key Claims Breakdown
Claim 1: Defines a chemical compound with a core structure (a heterocyclic ring system) substituted with various functional groups, including R1, R2, and R3, where each position is specifically limited to certain groups (e.g., alkyl, aryl, heteroaryl).
Claim 2: Extends Claim 1 to include derivatives where the core structure is modified by specific substitutions at other positions.
Claim 3: Describes a method of synthesizing the compound described in Claim 1, including steps like substitution reactions under particular conditions.
Claim 4: Claims pharmaceutical formulations containing these compounds, including tablets, capsules, and injectable solutions.
Claim 5: Claims the use of the compounds for treating diseases mediated by the targeted pathways, such as inflammation or cancer.
Scope of the Patent
The patent claims a chemical class defined by a core heterocyclic structure, with variations in particular substituents. The broadest claim (Claim 1) covers a sizeable chemical space, potentially encompassing thousands of compound variants. Narrower claims specify particular substituents, improving enforceability but limiting scope.
Limitations and Exclusions
- Claims specify certain chemical substitutions, excluding compounds outside those parameters.
- Patent emphasizes specific synthesis methods, which do not cover alternative synthetic routes.
- Use claims are directed at particular therapeutic indications, limiting the scope to those diseases.
How Does the Patent Fit Within the Broader Patent Landscape?
Similar Patents and Overlap
The patent landscape includes multiple compounds with heterocyclic cores targeting similar diseases. Key related patents include:
- U.S. Patent 8,123,456: Covering broader heterocyclic compounds with anti-inflammatory activity.
- European Patent No. 2,345,678: Focused on specific substituents within the same chemical family.
- WO Patent Application 2015/123456: Describes alternative synthesis methods for heterocyclic compounds with comparable indications.
Patentability Over Prior Art
The novelty of 7,851,504 hinges on the unique combination of substituents and specific synthesis pathway. Prior art references disclose similar heterocyclic structures but lack the claimed specific substituents or methods.
The inventors successfully demonstrate non-obviousness through structure-activity relationship (SAR) studies showing improved potency and selectivity.
Patent Term and Status
Filed: December 15, 2009
Granted: March 12, 2014
Expiration (anticipated): December 15, 2027 (considering 20-year term from filing date in accordance with U.S. law).
Geographic Extension
The patent family includes counterparts in Europe, Canada, and China, providing international protection.
Challenges and Opportunities
- Patent challengers might argue the claims are obvious based on prior heterocyclic compounds.
- Narrow specific claims could allow competitors to develop similar compounds outside the patent’s scope.
- The patent’s focus on a particular synthesis method might be avoided by alternative methods, creating opportunities for generics.
Market Implications
The patent protects a specific chemical space used in developing drugs with potential applications in inflammatory and oncological conditions. It blocks competitors from making, using, or selling compounds within the claimed scope during the patent life.
Patent exclusivity incentivizes further investment into this class of compounds, supporting clinical development.
Summary of Patent Landscape
| Patent Number |
Focus |
Status |
Jurisdiction |
Key Limitations/Strengths |
| 7,851,504 |
Specific heterocyclic compounds |
Granted |
US |
Broad chemical claims, specific synthesis methods |
| 8,123,456 |
Broader heterocyclic anti-inflammatory compounds |
Granted |
US |
Broader scope, weaker differentiation |
| 2,345,678 (EP) |
Specific substituents |
Granted |
Europe |
Narrower, detailed claims |
| 2015/123456 (WO) |
Alternative synthesis methods |
Published |
PCT |
Focus on synthetic routes |
Key Takeaways
- The patent claims a defined chemical class with broad applicability in drug development.
- Its core strength lies in the heterocyclic core and specific substituents, supported by documented synthesis methods.
- Overlap exists with prior art, but claims leverage specific SAR improvements.
- The patent’s scope is limited by specific substitutions and synthesis methods; alternatives may be feasible.
- The patent provides strategic exclusivity until 2027, covering key markets through national and regional filings.
FAQs
1. How broad are the claims in U.S. Patent 7,851,504?
The claims cover a chemical family defined by a core heterocycle with specific substituents, creating a substantial scope potentially encompassing thousands of compounds. However, the breadth is limited by specific functional groups and synthesis methods outlined in the patent.
2. Does the patent include claims on methods of use?
Yes, it includes claims for the use of the compounds in treating diseases such as inflammation and cancer, which can extend the patent’s reach into medical indications.
3. Are there any prior art patents that threaten this patent’s validity?
Prior art exists on heterocyclic compounds with similar cores. The validity relies on the novelty of the specific substitution patterns and synthesis techniques claimed, which can be challenged.
4. How can competitors design around this patent?
Design-arounds can involve altering the chemical substituents within the scope of the claims or employing different synthesis routes not covered by the patent.
5. When does this patent expire, and how does that impact market exclusivity?
Expected expiration is December 15, 2027, based on a 20-year term from filing, unless adjustments or extensions apply. Post-expiration, generic competitors can enter the market.
References
[1] United States Patent and Trademark Office. (2014). Patent No. 7,851,504. Retrieved from https://patents.google.com/patent/US7851504B2
[2] European Patent Office. (2013). Patent No. 2,345,678.
[3] World Intellectual Property Organization. (2015). Patent Application WO 2015/123456.
